case_images: PMC4332463_01
case_images: Bimorphic tumour with papillary carcinoma and sarcoma components, black and blue arrows, respectively (H&E x100).
case_images: CRIS2015-494383.001.jpg
case_images: PMC4332463_01_CRIS2015-494383.001.jpg
case_images: fig1
case_images: Histopathology has documented that E-cadherin, HBME-1, galectin-3, pancytokeratin, and keratin-19 staining were positive in papillary component (Figures 1 and 2).
case_images: Positive immunoreactivity with HBME-1 antibody in the papillary carcinoma component (x40).
case_images: CRIS2015-494383.002.jpg
case_images: PMC4332463_01_CRIS2015-494383.002.jpg
case_images: fig2
case_images: Histopathology has documented that E-cadherin, HBME-1, galectin-3, pancytokeratin, and keratin-19 staining were positive in papillary component (Figures 1 and 2).
case_images: Positive immunoreactivity with vimentin antibody in the sarcoma component (x40).
case_images: CRIS2015-494383.003.jpg
case_images: PMC4332463_01_CRIS2015-494383.003.jpg
case_images: fig3
case_images: In addition, spindle cell components were recognized with vimentin positivity (Figure 3).